Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice

Vaccine

Volumn 24, Issue 7, 2006, Pages 948-956

  Sharma, Sharad Kumar ^a   Farah, Deba ^a   Misra Bhattacharya, Shailja ^b   Bajpai, Preeti ^b   Agarwal, Anshu ^c   Mohammad, Owais ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug resistance; Escheriosome; Immunotherapy; Malaria; Vaccine

Indexed keywords

BLOOD GROUP ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; ESCHERIOSOME; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; LIPOSOME; MALARIA VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENCAPSULATION; ESCHERICHIA COLI; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; MALARIA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN ANALYSIS; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROCYTES; FEMALE; IMMUNIZATION; INTERFERON TYPE II; LIPOSOMES; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII; T-LYMPHOCYTES, CYTOTOXIC;

EID: 31844452063     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.063     Document Type: Article

References (41)

1. D. Butler, J. Maurice, and C. O'Brien Time to put malaria control on the global agenda Nature 386 1997 535 540
2. J. Cohen Bumps on the vaccine road Science 265 1994 1371 1380
3. J. Langhorne, S.J. Quin, and L.A. Sanni Mouse models of blood stage malaria infections: immune responses and cytokines involved in protection and pathology P. Perlmann M. Troye-Blomberg Malaria Immunology 2002 Karger Basel, Switzerland 204 228
4. J.M. Burns, D.D. Patricia, and D.M. Russo Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood stage antigens Infect Immun 65 1997 3138 3145
5. + T lymphocytes specific for an epitope of 16 kD a crystalline antigen of Mycobacterium tuberculosis Eur J Immunol 28 1998 1753 1761
6. J.L. Flynn, M.M. Goldstein, K.J. Triebold, B. Koller, and B.R. Bloom Major histocompatibility complex class I restricted T-cells are required for resistance to Mycobacterium tuberculosis infection Proc Natl Acd Sci USA 89 1992 12013 12017
7. + T-cells in the protective immune response to Plasmodium chabaudi in vivo Immunol Lett 25 1990 101 107
8. +T-cells Int Immunol 3 1991 587 597
9. S.P. Nickell, G.A. Stryker, and C. Arevalo Isolation from Trypanosoma crusi infected mice of CD8+ MHC-restricted cytotoxic T-cells that lyse parasite infected target cells J Immunol 150 1993 1446 1457
10. S.P. Pamela, S.C. Bosshardt, V. Uddhayukumar, L. Xiao, M. Kidd, and R.L. Hunter Prolonged expression of IFN-γ induced by protective blood-stage immunization against PlasmodiumyoeHi malaria Vaccine 18 1999 173 180
11. S. Zhong, M.F. Tarn, D. Jankovic, and M. Stevenson Vaccination with novel immunostimulatory adjuvants against blood stage antigens Infect Immun 71 2003 5178 5187
12. R.L. Hunter, M.R. Kidd, M.R. Olsen, P.S. Patterson, and A.A. Lal Induction of long lasting immunity to Plasmodium yoelii malaria with whole blood stage antigens and co-polymer adjuvants J Immunol 154 1995 1762 1769
13. J. Melancon-Kaplan, J. Burns Jr., A. Vaidya, H.K. Webster, and W.P. Weidanz The immunology of malaria K. Warren The Immunology and Molecular biology of parasitic diseases 1992 Alan R. Liss New York 300 362
14. N.T. Blomberg, W.P. Weidanz, and H. Heyde The role of T-cells in immunity to malaria and pathogenesis of disease M. Wahlgren Malaria molecular and clinical aspects 1999 Harwood Acad. Publishers Netherlands 403 427
15. K. Mohan, and M.M. Stevenson Acquired immunity to asexual blood stages I.W. Sherman Malaria: parasite biology, pathogenesis, and protection 1998 American Soc. Microbiol Washington, DC 467 493
16. +T-cell responses with out antibody formation J Immunol 149 1992 1334 1339
17. N. Ahmad, A.K. Masood, and M. Owais Fusogenic potential of prokaryotic membrane lipids: Implication in vaccine development Eur J Biochem 268 2001 5667 56675
18. + cytotoxic T-cell response Vaccine 21 2003 2383 2393
19. Dutta GP, Pandey A. Selection of multiple drug and antibiotic resistant strains of rodent malaria parasite Plasmodium yoelii nigeriensis Abstract second Asian Congress of Parasitogy, Lucknow, India. 1986. p. 9.
20. W.S. Singleton, M.S. Gray, and M.L. Brown A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions J Am Oil Chem Soc 42 1965 53 56
21. F.H. Amante, and M.F. Good Prolonged Th-1 like response generated by a Plasmodium yoelii specific T-cell clone allows complete clearance of infection in reconstituted mice Parasite Immunol 19 1997 111 126
22. M. Owais, and C.M. Gupta Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development Eur J Biochem 267 2000 3946 3956
23. B.B. Mishell, and S.M. Shiigi Selected Methods in Cellular Immunology 1980 W.H. Freeman and Company New York 23 24
24. T.R. Mosmann, and T. Fong Specific assays for cytokine production by T-cells J Immunol Methods 116 1989 151 158
25. J.N. Agrewala, M. Owais, C.M. Gupta, and G.C. Mishra Antigen incorporation into liposomes results in the enhancement of IL-4 and IgGl secretion: evidence for preferential expansion of Th-2 cells Cytokines Mol Ther 2 1996 59 65
26. 4 Nature 227 1970 680
27. S. Misra, D.P. Singh, M. Dikshit, and R.K. Chatterjee Functional antigenic molecules of different life stages of rodent filariid. A. viteae and their cross reactivity with human filariae (W. banchrofti) sera Trop Med 36 1994 35
28. S. Kumar, and H.L. Miller Cellular mechanisms in immunity to blood stage infection Immunol Lett 25 1990 109 114
29. - γδ T-cell subset in the spleens of mice during blood stage malaria J Immunol 151 1993 6311 6317
30. + T-cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria J Immunol 144 1990 1069 1074
31. F. Erard, and G.Le. Gros Th2-like CD8 T-cells: Their role in protection against infectious diseases Parasitol Today 10 1994 313 316
32. F. Gerosa, C. Paganin, D. Peritt, F. Paiola, M.T. Scupoli, and M.A. Amezaga Interleukin-12 primes human CD4 and CD8 T-cell clones for high production of both IFN-γ and Inteleukin-10 J Exp Med 183 1996 2559 2569
33. J.M. Batchelder, F.K. Cigel, H.C. Ternes, H.C. Vander Heyde, and W.P. Weidanz Type 1 but not Type 2 cytokines are required for the activation of both cell mediated and antibody mediated immunity in experimental malaria Am J Trop Med Hyg Suppl 57 1997 266a
34. + T-cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection Eur J Immunol 24 1994 158 164
35. L. Krishnan, C.J. Dicaire, G.B. Patel, and G.D. Sprott Archeosome vaccine adjuvants induce strong humoral, cell mediated and memory responses: comparison to conventional liposomes and alum Infect Immun 68 2000 54 63
36. J.W. Conlan, L. Krishnan, G.E. Willick, G.B. Patel, and G.D. Sprott Immunization of mice with lipopeptide antigen encapsulated in novel liposomes prepared from polar lipids of various archaebacteria elicits rapid and prolonged specific immunity against infection with the facultative intracellular pathogen Lysteria monocytogenes Vaccine 19 2001 3509 3517
37. C.V. Harding, D.S. Collins, O. Kannangawa, and E.R. Unanue Liposome encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation J Immunol 147 1991 2860 2863
38. R.R. Freeman, A.J. Trejdosiewicz, and G.A.M. Cross Protective monoclonal antibodies recognizing stage specific merozoite antigens of a rodent malaria parasite Nature 284 1980 366 368
39. I.W. Wendy, B.E. Charles, and W.T. Diane Antimalarial antibodies of IgG2a isotype modulate parasitaemia in mice infected with P. yoelii Infect Immun 59 1991 3547 3554
40. L.F. Fries, D.M. Gordon, R.L. Richards, J.E. Egan, M.R. Hollingdale, and M. Gross Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy Proc Natl Acad Sci USA 89 1992 358 362
41. R.L. Richards, M. Rao, N.M. Wassef, G.M. Glenn, S.W. Rothwell, and C.R. Alving Liposome containing lipid A serve as an adjuvant for induction of antibodies and cytotoxic T-cell responses against RTS, S malaria antigen Infect Immun 66 1998 2859 2865